Table 3.
Comparison of characteristics of adults with hypertension with uncontrolled baseline BP between baseline and the last visit during the intervention period (N = 277)
| Baseline: last visit before February 2016 | Intervention: latest visit between February 2016 and July 2016 | P value | |
|---|---|---|---|
| Initial BP | |||
| SBP, mm Hg | 147 (0.65) | 131 (0.81) | <.0001 |
| DBP, mm Hg | 88 (0.52) | 79 (0.60) | <.0001 |
| AOBP | |||
| SBP, mm Hg | NA | 147 (2.61) | NA |
| DBP, mm Hg | NA | 91 (1.96) | NA |
| Patients prescribed BP medications, No. (%) | 235 (84.8) | 241 (87.0) | .2213 |
| α1‐Receptor blocker, % | 12.6 | 14.1 | .2489 |
| ACEI or ARB, % | 59.9 | 60.6 | .7636 |
| β‐Blocker, % | 30.7 | 28.9 | .3182 |
| Dihydropyridine CCB, % | 37.2 | 41.9 | .0578 |
| Nondihydropyridine CCB, % | 3.6 | 4 | .3182 |
| Diuretic, % | 71.5 | 72.2 | .7582 |
| Thiazide‐type, % | 69 | 68.6 | .8843 |
| Loop, % | 9.7 | 9 | .5281 |
| Potassium‐sparing, % | 3.6 | 3.2 | .5646 |
| Aldosterone antagonist, % | 4 | 4.3 | .7395 |
| Therapeutic inertia,%* | 43.5 | 37.6 | .5429 |
| ΔSBP/RxΔ, mm Hg | −8.3 (2.0) | −21.6 (2.1) | .0004 |
Data are presented as mean and standard error or number (percentage). Automated office blood pressure (AOBP) is the mean of three readings with the patient alone in an examination room).
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; DBP, diastolic blood pressure; ΔSBP; RxΔ, change in systolic blood pressure after the most recent visit with intensification of antihypertensive medications for uncontrolled hypertension; NA, not available; SBP, systolic blood pressure.
*Percentage of visits with uncontrolled blood pressure (BP) with no change in antihypertensive medications.